KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Deferred Revenue (2020 - 2025)

Pfizer (PFE) has disclosed Current Deferred Revenue for 6 consecutive years, with $784.0 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 48.11% to $784.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $784.0 million through Dec 2025, down 48.11% year-over-year, with the annual reading at $784.0 million for FY2025, 48.11% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $784.0 million at Pfizer, down from $924.0 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $6.2 billion in Q4 2022, with the low at $784.0 million in Q4 2025.
  • Average Current Deferred Revenue over 5 years is $2.4 billion, with a median of $2.4 billion recorded in 2023.
  • The sharpest move saw Current Deferred Revenue soared 175.56% in 2021, then tumbled 66.19% in 2023.
  • Over 5 years, Current Deferred Revenue stood at $3.1 billion in 2021, then dropped by 17.84% to $2.5 billion in 2022, then rose by 7.14% to $2.7 billion in 2023, then crashed by 44.04% to $1.5 billion in 2024, then tumbled by 48.11% to $784.0 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $784.0 million, $924.0 million, and $1.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.